Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04637321 · ClinicalTrials.gov registry record
The Incidence and Risk Factors for Clostridioides Difficle Infection in Solid Organ Transplant Recipients
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 585
- Enrollment target
NCT04637321: Completed study, sponsored by Methodist Health System.
NCT04637321 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 585 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04637321 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 585 participants
- Enrollment target
Study Summary
2.1. Study Objectives * Primary Objective(s) * Identify the incidence and risk of CDI within one year after kidney, liver, and/or pancreas transplant * Secondary Objective(s) * Identify the risk factors for recurrent CDI post-transplant in patients who were diagnosed with a CDI within one year prior to Solid Organ Transplant * Evaluate the impact of CDI on graft survival following Solid Organ Transplant
Primary Outcome
Incidence of C. Difficile infection within one year post-transplant for CDI post-transplant.
Interventions
- PROCEDURE Solid organ transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 585 participants |
| Start Date | 2019-11-04 |
| Est. Completion | 2020-08-07 |
What the finished NCT04637321 record still lists
NCT04637321 is an observational study that tracks outcomes without assigning an intervention. The registered 585 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Solid organ transplant is the first listed.
NCT04637321 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04637321 about?
NCT04637321 is a clinical study titled "The Incidence and Risk Factors for Clostridioides Difficle Infection in Solid Organ Transplant Recipients". 2.1. Study Objectives * Primary Objective(s) * Identify the incidence and risk of CDI within one year after kidney, liver, and/or pancreas transplant * Secondary Objective(s) * Identify the risk factors for recurrent CDI post-transplant in patients who were diagnosed with a CDI within one year prio...
What is the current status of trial NCT04637321?
This trial is currently completed. The enrollment target is 585 participants. The study started on 2019-11-04. Estimated completion is 2020-08-07.
What interventions are being tested in trial NCT04637321?
The interventions under investigation include: Solid organ transplant (PROCEDURE).
Who is sponsoring clinical trial NCT04637321?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02803957 · 585 participants · NA
Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair
- NCT06680869 · 585 participants · Phase 3
Early Amiodarone in Shockable Cardiac Arrest
- NCT04134260 · 586 participants · Phase 3
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial
- NCT06100770 · 586 participants
Aveir AR Coverage With Evidence Development (CED) Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI